Neogen Corporation · Healthcare · Diagnostics & Research
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
At close
$10.74
−$0.49 (−4.40%) Close
Prev closePrevC$11.23
OpenOpen$11.24
Day highHigh$11.24
Day lowLow$10.74
VolumeVol1,157
Avg volAvgVol3,060,299
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$2.44B
P/E ratio
-3.88
FY Revenue
$880.32M
EPS
-2.77
Gross Margin
45.98%
Sector
Healthcare
AI report sections
MIXED
NEOG
Neogen Corporation
No AI report section text found yet for this symbol.
Why Neogen Stock Blasted More Than 31% Higher Today
Neogen stock surged over 31% after posting a beat-and-raise fiscal Q2 earnings report. Despite revenue declining nearly 3% year-over-year to $224.7 million and net income dropping slightly, the company crushed analyst expectations and raised full-year guidance. However, the analyst expresses caution about the stock's future, noting the revenue decline and suggesting investors may be overexcited about the results.
NEOGearnings beatguidance raiserevenue declinestock surgehealthcare companyfood and animal safety
Sentiment note
While the stock experienced a significant 31% price jump due to beating estimates and raising guidance, the underlying fundamentals show declining revenue and profitability year-over-year. The analyst explicitly warns against overexcitement, noting the lack of revenue growth is concerning. The positive sentiment from the market reaction is tempered by fundamental weakness, warranting a neutral stance.
PositiveBenzinga• Business Wire
Neogen® Renews Official Sponsorship with US Equestrian to Continue Advancing Equine Health Education
Neogen Corporation has renewed its sponsorship with US Equestrian, focusing on educational materials about equine botulism prevention and treatment. The collaboration aims to raise awareness about the potentially deadly neurotoxin and promote horse health through scientific resources.
Company is expanding its partnership, demonstrating commitment to equine health education, and showcasing leadership in developing preventive solutions like the BotVax® B vaccine
NEOG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neogen Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
A class action lawsuit has been filed against Neogen Corporation alleging false and misleading statements about company integration and financial performance during the period of January 5, 2023 to June 3, 2025.
The lawsuit alleges the company made materially false statements about its integration process, downplayed operational inefficiencies, and surprised investors with a significant decline in EBITDA margin from 22% to high-teens, indicating potential misrepresentation of financial performance
NegativeGlobeNewswire Inc.• Claimsfiler
NEOGEN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Neogen Corporation - NEOG
Neogen Corporation faces a securities class action lawsuit alleging failure to disclose material information during January 5, 2023 to June 3, 2025, with stock price dropping significantly after revenue and earnings guidance announcements.
Stock price dropped 28% after Q4 revenue decrease, CEO departure, and lowered earnings guidance, indicating significant investor and market confidence loss
NegativeGlobeNewswire Inc.• Rosen Law Firm
NEOG DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Neogen Corporation Investors to Secure Counsel Before Important September 16 Deadline in Securities Class Action – NEOG
Rosen Law Firm alerts Neogen Corporation investors about a September 16, 2025 deadline for a securities class action lawsuit related to allegedly misleading statements about company integration and performance.
The lawsuit alleges that company executives made false or misleading statements about their integration process, downplaying inefficiencies and overstating performance, which potentially misled investors
NEOG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neogen Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
A class action lawsuit has been filed against Neogen Corporation alleging false and misleading statements about company integration and financial performance during the period of January 5, 2023 to June 3, 2025.
The lawsuit alleges the company made materially false statements about its integration process, downplayed operational inefficiencies, and surprised investors with a significant decline in EBITDA margin from 22% to high-teens, indicating potential misrepresentation of financial performance
NEOGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Neogen Corporation - NEOG
Kahn Swick & Foti, LLC alerts investors about a class action lawsuit against Neogen Corporation for allegedly failing to disclose material financial information between January 5, 2023 and June 3, 2025, resulting in significant stock price declines.
Stock price dropped 28% after disclosing revenue decrease, reduced fiscal year guidance, CEO departure, and significant EBITDA margin decline, indicating serious financial and operational challenges
NEOG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neogen Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
A class action lawsuit has been filed against Neogen Corporation alleging false and misleading statements about company integration and financial performance during the period of January 5, 2023 to June 3, 2025.
The lawsuit alleges the company made materially false statements about its integration progress, downplayed operational inefficiencies, and surprised investors with a significant EBITDA margin decline from 22% to high-teens, indicating potential financial misrepresentation
NEOGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Neogen Corporation and Encourages Investors to Contact the Firm
A class action lawsuit has been filed against Neogen Corporation alleging misrepresentation of 3M integration status and financial performance, with stock price declining significantly after revealing integration challenges and cutting financial guidance.
Stock price dropped multiple times due to revealed integration issues, goodwill impairment, material weaknesses in financial reporting, revenue decline, CEO resignation, and reduced profit margin expectations
NegativeBenzinga• Business Wire
Neogen Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - NEOG
Neogen Corporation faces a class action lawsuit alleging false statements about the integration of a former 3M food safety business, with claims of misleading investors about integration progress and margin performance.
The company is being sued for allegedly making false and misleading statements about business integration, which resulted in investor damages and a material decline in margin performance
NegativeGlobeNewswire Inc.• Globe Newswire
NEOGEN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Neogen Corporation - NEOG
Neogen Corporation faces a securities class action lawsuit alleging failure to disclose material information during January 2023 to June 2025, with stock price dropping significantly after revenue and EBITDA margin disclosures.
Stock price dropped 28% after Q1 revenue decrease, CEO departing, lowered financial guidance, and additional 17% drop after poor EBITDA margin projection, indicating significant investor confidence loss
NegativeGlobeNewswire Inc.• Law Offices Of Howard G. Smith
DEADLINE ALERT for NEOG, RXST, RMHIX, FI: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions
Law firm alerts investors about potential securities fraud class action lawsuits for multiple companies, highlighting alleged misleading statements and financial misrepresentations across different sectors.
Allegations of misleading statements about 3M integration, potential goodwill impairment, and impact on financial performance
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal
